Dermatology

Research has demonstrated that the use of dual cytokine blockers can mitigate toxic reactions, including graft-versus-host-disease…

New research has revealed that a high-fibre diet has been linked to an increased progression-free survival (PFS) in patients with melanoma…

IMBALANCE in the gut’s microbiome, caused by a diet high in sugar and fats, may contribute to inflammatory skin diseases such as psoriasis…

NEW research methodologies, which take advantage of enzymes in order to breakdown bacteria living on human skin, have revealed novel…

A study by Kim Papp looked at ruxolitinib as a topical cream for AD. Ruxolitinib works by inhibiting JAK1 and JAK2 on the cell surface and consequently affects the signalling cascade that would eventually produce pro-inflammatory cytokines.

PSORIASIS is a painful inflammatory skin disease that affects approximately 125 million individuals worldwide. Currently, there is no cure for psoriasis.

HOME healthcare systems are critical for improving medical care during infectious disease epidemics and for overcoming the growing challenges of an…

MASS testing for coronavirus disease (COVID-19) has been identified by the World Health Organization (WHO) and many governments as a key strategy to…